Critical Review: Olympus (OTCMKTS:OCPNY) & Cooper Companies (NASDAQ:COO)

Olympus (OTCMKTS:OCPNY – Get Free Report) and Cooper Companies (NASDAQ:COO – Get Free Report) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, analyst recommendations, earnings, institutional ownership and dividends.

Institutional and Insider Ownership

0.0% of Olympus shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Olympus and Cooper Companies, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Olympus 0 0 1 0 3.00
Cooper Companies 2 13 4 0 2.11

Cooper Companies has a consensus price target of $68.60, suggesting a potential upside of 21.25%. Given Cooper Companies’ higher probable upside, analysts clearly believe Cooper Companies is more favorable than Olympus.

Earnings & Valuation

This table compares Olympus and Cooper Companies”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Olympus $7.74 billion 2.99 $1.03 billion $0.82 21.95
Cooper Companies $4.24 billion 2.54 $374.90 million $2.93 19.31

Olympus has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Olympus, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Olympus has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.

Profitability

This table compares Olympus and Cooper Companies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Olympus 13.80% 24.30% 9.30%
Cooper Companies 13.46% 10.90% 7.24%

Summary

Olympus beats Cooper Companies on 8 of the 14 factors compared between the two stocks.

About Olympus

(Get Free Report)

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

About Cooper Companies

(Get Free Report)

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.